Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
Silent aspiration and recovery from Dysphagia in a case of bickerstaff brainstem encephalitis.
Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity.
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
Off-pump coronary surgery in a patient with multiple sclerosis.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Role of vitamin D in acquired immune and autoimmune diseases.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
In vivo quantitative whole-brain T1 rho MRI of multiple sclerosis.
Oligodendrocytes: Myelination and Axonal Support.
A case of neuromyelitis optica associated with anti-aquaporin 4 antibody and other autoantibodies.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
Future MRI tools in multiple sclerosis.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
[Diet and multiple sclerosis].

Pages